Trevi Therapeutics Inc
TRVI
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.87B
Close$
$0.13
99% downside
Current Fair Value
99% downsideOvervalued by 99% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.87 Billion |
|---|---|
| Enterprise Value | $1.82 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.29 |
| Beta | 0.98 |
| Outstanding Shares | 156,602,158 |
Return
| Return on Equity | -15.90% |
|---|---|
| Return on Assets | -15.46% |
| Return on Invested Capital | -17.69% |
Valuation & Multiples
| P/E Ratio | -39.05 |
|---|---|
| PEG | -87.39 |
| Price to Sales | - |
| Price to Book Ratio | 6.06 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -31.95 |
| Enterprise Value to Net Income | -36 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 3.36% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 95.77% |
|---|---|
| Total Invested | $430,363▼ 99.98% |
| Investors Holding | 5▼ 221.00% |
ESG Score
No data